Abstract

Background

Guidance on the recommended durations of antibiotic therapy, the use of oral antibiotic therapy, and the need for repeat blood cultures remain incomplete for gram-negative bloodstream infections. We convened a panel of infectious diseases specialists to develop a consensus definition of uncomplicated gram-negative bloodstream infections to assist clinicians with management decisions.

Methods

Panelists, who were all blinded to the identity of other members of the panel, used a modified Delphi technique to develop a list of statements describing preferred management approaches for uncomplicated gram-negative bloodstream infections. Panelists provided level of agreement and feedback on consensus statements generated and refined them from the first round of open-ended questions through 3 subsequent rounds.

Results

Thirteen infectious diseases specialists (7 physicians and 6 pharmacists) from across the United States participated in the consensus process. A definition of uncomplicated gram-negative bloodstream infection was developed. Considerations cited by panelists in determining if a bloodstream infection was uncomplicated included host immune status, response to therapy, organism identified, source of the bacteremia, and source control measures. For patients meeting this definition, panelists largely agreed that a duration of therapy of ~7 days, transitioning to oral antibiotic therapy, and forgoing repeat blood cultures, was reasonable.

Conclusions

In the absence of professional guidelines for the management of uncomplicated gram-negative bloodstream infections, the consensus statements developed by a panel of infectious diseases specialists can provide guidance to practitioners for a common clinical scenario.

Details

Title
Optimizing the Management of Uncomplicated Gram-Negative Bloodstream Infections: Consensus Guidance Using a Modified Delphi Process
Author
Heil, Emily L 1 ; Bork, Jacqueline T 2 ; Abbo, Lilian M 3 ; Barlam, Tamar F 4 ; Cosgrove, Sara E 5 ; Davis, Angelina 6 ; Ha, David R 7 ; Jenkins, Timothy C 8 ; Kaye, Keith S 9 ; Lewis, James S, II 10 ; Ortwine, Jessica K 11 ; Pogue, Jason M 12 ; Spivak, Emily S 13 ; Stevens, Michael P 14 ; Vaezi, Liza 15 ; Tamma, Pranita D 16 

 Department of Pharmacy Practice and Science, University of Maryland School of Pharmacy, Baltimore, Maryland, USA 
 Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA 
 Department of Medicine, University of Miami Miller School of Medicine, Jackson Health System, Miami, Florida, USA 
 Department of Medicine, Boston University School of Medicine, Boston, Massachusetts, USA 
 Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA 
 Division of Infectious Diseases, Duke Antimicrobial Stewardship Outreach Network, Durham, North Carolina, USA 
 Department of Quality and Patient Safety, Stanford Antimicrobial Safety and Sustainability Program, Stanford, California, USA 
 Department of Medicine, Denver Health, Denver, Colorado, USA 
 Department of Medicine, University of Michigan Medical School, Ann Arbor, Michigan, USA 
10  Department of Pharmacy, Oregon Health and Science University, Portland, Oregon, USA 
11  Department of Pharmacy, Parkland Health & Hospital System, Dallas, Texas, USA 
12  Department of Clinical Pharmacy, University of Michigan College of Pharmacy, Ann Arbor, Michigan, USA 
13  Department of Medicine, University of Utah School of Medicine, Salt Lake City, Utah, USA 
14  Department of Medicine, Virginia Commonwealth University School of Medicine, Richmond, Virginia, USA 
15  Department of Pharmacy, Virginia Mason Medical Center, Seattle, Washington, USA 
16  Department of Pediatrics, Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA 
Publication year
2021
Publication date
Oct 2021
Publisher
Oxford University Press
e-ISSN
23288957
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3170969064
Copyright
© The Author(s) 2021. Published by Oxford University Press on behalf of Infectious Diseases Society of America. This work is published under https://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.